Pediatric CAP: Lower-Dose, Shorter Duration Amoxicillin Effective in Study

Trial finds 3 days of lower dose noninferior to higher-dose, 7 day regimen Although amoxicillin is widely recognized for treatment of community acquired pneumonia (CAP) in young children, the optimal dose and optimal duration of therapy remain unclear, as neither have been widely studied. For example, in 2011 the Infectious Diseases Society of America recommended

Related Keywords

United States ,Canada ,Michigan ,America ,Canadian ,Peggy Peck ,Juliaa Bielicki ,St George University Of London ,Pediatric Infectious Diseases Research Group ,Institute For Infection ,Health Technology Assessment Program ,Infectious Diseases Society Of America ,Infectious Diseases Society ,Medical Research Council Clinical Trial Unit ,University College London ,Technology Assessment Program ,Antimicrobial Resistance Themed ,